School of Public Health, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, The University of Queensland, School of Public Health, Herston, Queensland, Australia.
Ann Behav Med. 2024 Oct 18;58(11):729-740. doi: 10.1093/abm/kaae048.
Many individuals with lung cancer and chronic obstructive pulmonary disease (COPD) experience high levels of stigma, which is associated with psychological distress and delayed help-seeking.
To identify interventions aimed at reducing the stigma of lung cancer or COPD and to synthesize evidence on their efficacy.
A systematic review was conducted by searching PubMed, Scopus, PsycINFO, and CINAHL for relevant records until March 1, 2024. Studies were eligible if they described an intervention designed to reduce internalized or external stigma associated with COPD or lung cancer and excluded if they did not report empirical findings.
We identified 476 papers, 11 of which were eligible for inclusion. Interventions included educational materials, guided behavior change programs, and psychotherapeutic approaches. Interventions targeted people diagnosed with, or at high risk of developing COPD or lung cancer or clinical staff. No interventions that aimed to reduce stigma associated with lung cancer or COPD in the general community were identified. Most interventions yielded a statistically significant reduction in at least one measure of stigma or a decrease in qualitatively reported stigma.
The emerging literature on interventions to reduce stigma associated with lung cancer and COPD suggests that such interventions can reduce internalized stigma, but larger evaluations using randomized controlled trials are needed. Most studies were in the pilot stage and required further evaluation. Research is needed on campaigns and interventions to reduce stigma at the societal level to reduce exposure to external stigma amongst those with COPD and lung cancer.
许多肺癌和慢性阻塞性肺疾病（COPD）患者经历着高度的污名化，这与心理困扰和寻求帮助的延迟有关。
确定旨在减少肺癌或 COPD 污名化的干预措施，并综合评估其疗效。
通过检索 PubMed、Scopus、PsycINFO 和 CINAHL，对截至 2024 年 3 月 1 日的相关记录进行了系统评价。如果研究描述了旨在减少与 COPD 或肺癌相关的内化或外化污名的干预措施，则符合纳入标准；如果未报告实证结果，则将其排除在外。
我们共确定了 476 篇论文，其中 11 篇符合纳入标准。干预措施包括教育材料、行为指导改变计划和心理治疗方法。干预对象包括已被诊断为 COPD 或肺癌或有发展风险的患者，或临床医护人员。未发现旨在减少普通人群中与肺癌或 COPD 相关污名化的干预措施。大多数干预措施至少在一项污名化测量指标上产生了统计学上的显著降低，或在定性报告的污名化方面有所减少。
关于减少与肺癌和 COPD 相关污名化的干预措施的新兴文献表明，这些干预措施可以减少内化污名化，但需要更多使用随机对照试验进行更大规模的评估。大多数研究处于试点阶段，需要进一步评估。需要研究在社会层面减少污名化的运动和干预措施，以减少 COPD 和肺癌患者面临的外部污名化。
